At Veranova, we specialize in the development, manufacturing and analytical testing of complex small molecules and novel modalities. As a leading drug substance CDMO, with over 50 years’ experience, our team of experts and cutting-edge instrumentation enables us to deliver life-changing complex chemistry solutions for our partners.
Get in touch
From early-phase development through to commercial manufacturing, Veranova provides integrated, flexible solutions to accelerate your program and reduce risk. Our network of R&D and GMP-certified sites in the US and Europe supports innovation at every stage.
By working closely with customers to ensure seamless knowledge and technology transfer, our fully integrated CDMO approach allows for a more efficient and cost-effective drug development process. Our experts in process and analytical chemistry, quality and production work together to produce solutions for scale-up, either at one of our GMP manufacturing sites or to another facility.
Visit our Technology Transfer page or download our white paper to find out more.
At Veranova, we have the technical capabilities to scale up your complex reactions with confidence. Read our white paper to find out how we can help you achieve the ‘right first time’ combination, improve drug availability, and reduce time to market.
By understanding the intrinsic properties of the drug substance, our experts aim to maximize the chances of success in preclinical studies. Via our in-house solid form analytical and preformulation team, we are able to support analytical requirements for IND applications and support early phase clinical studies. Read more on our Enabling Formulation page, and download our flyer.
Accelerating your therapeutic to market is our mission. But in today’s rapidly shifting development landscape, innovation is needed to overcome hurdles and ensure that outputs are delivered on time. Watch our keynote session, delivered by our CEO Mike Riley, to find out how Veranova is harnessing the power of AI to streamline pharmaceutical processing.
At Veranova, we recognize the importance of aligning our processes with the well-being of the planet. That’s why maximizing efficiency, reducing our environmental footprint and ensuring the highest standards of product safety is at the core of our mission. Visit our Corporate Responsibility page to learn more.
Our mission is to improve and save lives. With each product we touch directly impacting a patient’s life, it is critical that we maintain an uncompromising focus on quality, compliance, and excellence in delivery to our customers and the patients who depend on them. Find out more about our culture of rigorous quality management and continuous improvement on our Quality, Compliance & Regulatory Affairs page.
The sustainability of your business and processes is a central concern for us at Veranova. With 50 years’ experience building an extensive range of controlled substances and opioids, we leverage our expertise to provide reliable, secure access to these vital products and materials across our global facilities and GMP-compliant bulk production plants. Read more about supply security on our Controlled Substances page.
Our dedication goes beyond the lab, it is at the root of everything we do. By partnering with us, you can expect:
Our global project management team provides reliable oversight and coordination to keep your project on track and aligned with your goals. Key features of our project management services include:
With Veranova, you gain more than a CDMO, you gain a true project partner focused on meeting your goals efficiently, cost-effectively and maintaining high quality standards.
Leveraging our world-leading capabilities in polymorphs, salt forms, crystal morphology and controlled particles, we can help you advance your solid form science.
We were honored to welcome Nobel Prize laureate, Professor of Chemistry at Stanford University, and Veranova Advisory Board member, Carolyn Bertozzi to our SCALE 2025 Symposium event in July.
Listen to Carolyn’s talk where she discusses her decades-long work developing bioorthogonal and click chemistries, and how these innovations are enabling the construction of complex therapeutic modalities across pharma today.
Read our latest white paper highlighting critical analytical techniques necessary for the characterization of ADCs, emphasizing their physicochemical properties, biological activity, stability assessments, and regulatory implications.
In recent years, interest in psychedelics for therapeutic use has increased. Among these is psilocybin, the world’s most studied psychedelic compound for the treatment of mental health conditions. This Expert Insight explores the potential of this molecule, and the challenges associated with synthesizing it at scale.
Discover new ways to advance your science with Veranova.
Contact us